Track Nkarta's long-term debt ($66M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), NKTX shows a long-term debt of $66M. That compares with $140M in the prior-year period — down 53.7% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, NKTX's long-term debt is now $66M (was $140M) — a 53.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Nkarta is outperforming or lagging.
Tracking NKTX's long-term debt over time shows whether Nkarta is scaling, shrinking, or reshaping that part of the business. The current reading is $66M That compares with $140M in the prior-year period — down 53.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this long-term debt page, Stockcircle has Nkarta's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $66M) with ownership activity and broader fundamentals.
Nkarta's long-term debt is $66M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.